Metabolomics fingerprinting identifies redox-dependent inhibition of TXNIP alleviates renal fibrosis via modulation of TGF-β1/COL-1/ GRP78 signaling axis in a diabetic nephropathy rat model.
文献摘要
Diabetic nephropathy (DN) is a chronic metabolic disorder characterized by hyperglycaemia-induced disruption of renal homeostasis. Emerging evidence suggests that the TRX/TXNIP axis mediates oxidative stress and inflammation in DN. However, its specific role in regulating ER-mitochondrial dysfunction and renal fibrosis remains unclear. Streptozotocin (STZ)-induced diabetic rats exhibited a progressive decline in body weight and increased feed consumption from the 6 th week onward. These rats showed reduced renal antioxidant levels and elevated malondialdehyde (MDA) concentrations. Histopathological analysis revealed renal structural alterations, impaired kidney function, and increased accumulation of glycogen and type I collagen over time. Additionally, DN progression was associated with a gradual upregulation of TXNIP, α-SMA, and p-NF-κB, as demonstrated by immunohistochemistry. Immunoblot analysis revealed increased expression of TXNIP, COL-1, and TGF-β1, accompanied by decreased levels of TXN-2 and beclin-1. Silencing of TXNIP alleviated ER-mitochondrial dysfunction (GRP78 and DRP-1), reduced apoptosis (decreased cleaved caspase 3 and increased Bcl-2 levels), and suppressed fibrogenic markers (TGF-β1 and COL-1) in NRK-52E cells exposed to high glucose (HG). Furthermore, we performed integrated high-field 800 MHz Nuclear Magnetic Resonance (NMR) based metabolomics analysis of renal tissues to identify metabolic signatures associated with DN progression. The findings revealed time-dependent accumulation of branched-chain amino acids and decreased myo-inositol levels at 12 th week during the progression of DN. Collectively, these findings suggest that the TRX/TXNIP axis contributes to renal fibrosis through ER-mitochondrial cross-talk and metabolic alterations during the development of DN.